Skip to main content
. 2006 Dec 1;4(3):327–333. doi: 10.1093/ecam/nel093

Figure 4.

Figure 4.

Inhibition of LPS-activated p-IκBα protein expression and NF-κB activation by MCE. The level of the p-IκBα protein (A) was monitored for 15 min after treating the cells with LPS (1 μg ml−1) with or without the MCE pretreatment (i.e. 1 h before LPS treatment). NF-κB activation (B) from the nuclear extracts was analyzed by gel shift assay. Each lane contained 5 μg of the nuclear extracts. The results were confirmed by repeated analyses.

HHS Vulnerability Disclosure